Teva Gets Warner Chilcott's Atelvia Patents Invalidated
A New Jersey federal judge on Wednesday ruled invalid as obvious two patent claims covering Warner Chilcott Co. LLC's osteoporosis drug Atelvia, handing a win to Teva Pharmaceuticals USA Inc. after...To view the full article, register now.
Already a subscriber? Click here to view full article